New Approaches to Measuring Value in Oncology Therapy
Although clinical trial data have quantified patient survival gains associated with tyrosine kinase inhibitors in chronic myeloid leukemia, the overall value of these benefits is unknown.
Advertisement
Advertisement
Trending on AJMC
1
Flow Cytometry Tracks CAR T-Cell Therapy Persistence in Aggressive LBCL
2
Newly Identified RTEL1 Variant Could Broaden Genetic Landscape of Familial PF
3
Inside the VA’s Hub-and-Spoke Model for Multiple Sclerosis Care: Rebecca Spain, MD
4
2025 Hypertension Guideline Updates Presented at AHA Scientific Sessions
5
